Syringin alleviates bisphenol A-induced spermatogenic defects and testicular injury by suppressing oxidative stress and inflammation in male zebrafish
Copyright © 2024 Elsevier B.V. All rights reserved..
Syringin (SRG) is a bioactive principle possessing extensive activities including scavenging of free radicals, inhibition of apoptosis, and anti-inflammatory properties. However, its effects on spermatogenic defects and testicular injury as well as the underlying mechanisms are still unclear. This study aims to investigate the protective effect of SRG on testis damage in zebrafish and explore its potential molecular events. Zebrafish testicular injury was induced by exposure to bisphenol A (BPA) (3000 μg/L) for two weeks. Fish were treated with intraperitoneal injection of SRG at different doses (5 and 50 mg/kg bodyweight) for two more weeks under BPA induction. Subsequently, the testis and sperm were collected for morphological, histological, biochemical and gene expression examination. It was found that the administration of SRG resulted in a significant protection from BPA-caused impact on sperm concentration, morphology, motility, fertility rate, testosterone level, spermatogenic dysfunction and resulted in increased apoptotic and reactive oxygen species' levels. Furthermore, testicular transcriptional profiling alterations revealed that the regulation of inflammatory response and oxidative stress were generally enriched in differentially expressed genes (DEGs) after SRG treatment. Additionally, it was identified that SRG prevented BPA-induced zebrafish testis injury through upregulation of fn1a, krt17, fabp10a, serpina1l and ctss2. These results indicate that SRG alleviated spermatogenic defects and testicular injury by suppressing oxidative stress and inflammation in male zebrafish.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:131 |
---|---|
Enthalten in: |
International immunopharmacology - 131(2024) vom: 20. Apr., Seite 111830 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhao, Ye [VerfasserIn] |
---|
Links: |
---|
Themen: |
Benzhydryl Compounds |
---|
Anmerkungen: |
Date Completed 10.04.2024 Date Revised 10.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.intimp.2024.111830 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370103637 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370103637 | ||
003 | DE-627 | ||
005 | 20240410232747.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240324s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.intimp.2024.111830 |2 doi | |
028 | 5 | 2 | |a pubmed24n1371.xml |
035 | |a (DE-627)NLM370103637 | ||
035 | |a (NLM)38520788 | ||
035 | |a (PII)S1567-5769(24)00348-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhao, Ye |e verfasserin |4 aut | |
245 | 1 | 0 | |a Syringin alleviates bisphenol A-induced spermatogenic defects and testicular injury by suppressing oxidative stress and inflammation in male zebrafish |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.04.2024 | ||
500 | |a Date Revised 10.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
520 | |a Syringin (SRG) is a bioactive principle possessing extensive activities including scavenging of free radicals, inhibition of apoptosis, and anti-inflammatory properties. However, its effects on spermatogenic defects and testicular injury as well as the underlying mechanisms are still unclear. This study aims to investigate the protective effect of SRG on testis damage in zebrafish and explore its potential molecular events. Zebrafish testicular injury was induced by exposure to bisphenol A (BPA) (3000 μg/L) for two weeks. Fish were treated with intraperitoneal injection of SRG at different doses (5 and 50 mg/kg bodyweight) for two more weeks under BPA induction. Subsequently, the testis and sperm were collected for morphological, histological, biochemical and gene expression examination. It was found that the administration of SRG resulted in a significant protection from BPA-caused impact on sperm concentration, morphology, motility, fertility rate, testosterone level, spermatogenic dysfunction and resulted in increased apoptotic and reactive oxygen species' levels. Furthermore, testicular transcriptional profiling alterations revealed that the regulation of inflammatory response and oxidative stress were generally enriched in differentially expressed genes (DEGs) after SRG treatment. Additionally, it was identified that SRG prevented BPA-induced zebrafish testis injury through upregulation of fn1a, krt17, fabp10a, serpina1l and ctss2. These results indicate that SRG alleviated spermatogenic defects and testicular injury by suppressing oxidative stress and inflammation in male zebrafish | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Bisphenol A | |
650 | 4 | |a RNA-Seq | |
650 | 4 | |a Syringin | |
650 | 4 | |a Testicular injury | |
650 | 4 | |a Zebrafish | |
650 | 7 | |a syringin |2 NLM | |
650 | 7 | |a I6F5B11C96 |2 NLM | |
650 | 7 | |a bisphenol A |2 NLM | |
650 | 7 | |a MLT3645I99 |2 NLM | |
650 | 7 | |a Benzhydryl Compounds |2 NLM | |
650 | 7 | |a Glucosides |2 NLM | |
650 | 7 | |a Phenols |2 NLM | |
650 | 7 | |a Phenylpropionates |2 NLM | |
700 | 1 | |a Luo, Xu |e verfasserin |4 aut | |
700 | 1 | |a Hu, Jinyuan |e verfasserin |4 aut | |
700 | 1 | |a Panga, Mogellah John |e verfasserin |4 aut | |
700 | 1 | |a Appiah, Clara |e verfasserin |4 aut | |
700 | 1 | |a Du, Zhanxiang |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Lin |e verfasserin |4 aut | |
700 | 1 | |a Retyunskiy, Vladimir |e verfasserin |4 aut | |
700 | 1 | |a Gao, Xing |e verfasserin |4 aut | |
700 | 1 | |a Ma, Bo |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Qi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 131(2024) vom: 20. Apr., Seite 111830 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
773 | 1 | 8 | |g volume:131 |g year:2024 |g day:20 |g month:04 |g pages:111830 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2024.111830 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 131 |j 2024 |b 20 |c 04 |h 111830 |